Verition Fund Management LLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$895,349
-30.5%
32,990
-21.3%
0.01%
-41.2%
Q2 2023$1,288,160
+94.5%
41,905
+127.9%
0.02%
+88.9%
Q1 2023$662,376
-47.9%
18,384
-42.9%
0.01%
-55.0%
Q4 2022$1,271,833
-7.3%
32,182
-52.9%
0.02%
+25.0%
Q3 2022$1,372,371
+266.0%
68,256
+665.8%
0.02%
+128.6%
Q2 2022$375,000
-79.3%
8,913
-80.8%
0.01%
-68.2%
Q1 2022$1,808,000
+146.3%
46,413
+128.6%
0.02%
+266.7%
Q3 2021$734,000
-45.8%
20,299
-38.5%
0.01%
-50.0%
Q2 2021$1,353,000
+430.6%
33,000
+463.7%
0.01%
+300.0%
Q1 2021$255,0005,8540.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$122,204,89747.65%
Vantage Consulting Group Inc 1,022,194$36,829,65020.91%
Indie Asset Partners, LLC 433,000$15,600,99018.22%
Overbrook Management Corp 578,783$20,853,5515.46%
Silicon Valley Community Foundation 1,032,320$37,194,4905.36%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,047,049$109,785,1754.64%
Geo Capital Gestora de Recursos Ltd 142,748$5,1433.81%
Renaissance Capital LLC 123,913$4,464,5853.31%
Rokos Capital Management LLP 1,106,813$40,077,6982.96%
Lagoda Investment Management, L.P. 101,500$3,657,0452.60%
View complete list of ROYALTY PHARMA PLC shareholders